Immunicum AB acquires patent from VirEx AB (Elicera Therapeutics)

October 27, 2014

Immunicum AB acquires a patent from VirEx AB (now Elicera Therapeutics) and simultaneously gives an exclusive global license for the development of an oncolytic virus (ELC-100) for the treatment of neuroendocrine tumors.

Download attachment (pdf)https://www.immunicum.se/wp-content/uploads/2014/10/Pressmeddelande-141027-VirEx.pdf
< Back to press releases